Silo Pharma, Inc.
SILO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $4 | $5 | $4 |
| - Cash | $4 | $4 | $3 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | -$0 | $2 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | -0% | 0% | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -1,291.2% | 91.9% | 91.9% | -2,118.3% |
| EBITDA | -$1 | -$1 | -$1 | -$2 |
| % Margin | -6,139.3% | -6,658.4% | -5,693.3% | -9,936.5% |
| Net Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | -6,160.5% | -6,681.2% | -5,721.9% | -9,600.7% |
| EPS Diluted | -0.12 | -0.19 | -0.23 | -0.39 |
| % Growth | 36.8% | 17.4% | 41% | – |
| Operating Cash Flow | -$1 | -$1 | -$2 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$2 | -$1 |